A much diminished 23andMe exists today, a far cry from the phenomenon that it was in the world consumer DNA testing. Could ...

This week, the FTC ordered Cerebral to pay a $7 million fine, accusing the company of mishandling users’ sensitive health ...

Don’t be surprised if soon there’s a supply chain shortage of expert witnesses for medical malpractice and other healthcare ...

Two Chairs, a startup offering hybrid behavioral health care, closed a $72 million Series C funding round. The company’s ...

Ilant Health, a virtual obesity management company, announced Wednesday that it extended its seed round from $3 million to $5.5 million. New York City-based Ilant Health is a value-based care ...

Pelago, a virtual clinic for substance use treatment, launched a contingency management program, in which members are rewarded for healthy behaviors like engaging in treatment, the company ...

A Roche cancer drug that treats lung cancer with a certain genetic signature now has an additional FDA approval that expands the applications of the blockbuster product. The drug, Alecensa, is ...

It may come as no surprise that healthcare in 2024 faces a paradox: Groundbreaking technologies like precision medicine and AI-driven diagnostics offer the promise of revolutionized patient care ...

The first quarter of 2024 saw a significant rise in M&A activity in the hospital and health system space, according to a new report from Kaufman Hall. Experts think that this M&A activity will ...

An experimental Parkinson’s disease drug on its way to AbbVie as part of an $8.7 billion acquisition has met the goals of a pivotal study, setting up the pharmaceutical giant with a drug ...